News Releases

(ALEXANDRIA, VA) April 29, 2008 – Oxford Finance Corporation, the principal lender, and Comerica Bank, today announced they have finalized a $15 million senior secured loan agreement with VisualSonics Inc. Both financial institutions are established providers of senior debt to the life science community.

Toronto, Ontario – October 7, 2008 -  VisualSonics announced today the launch of the Vevo 2100 micro imaging ultrasound platform that will drive ultrasound use in pre clinical imaging to a new level and will transform high resolution clinical ultrasound imaging.

Toronto, Ontario San Antonio, Texas – October 7, 2008 – VisualSonics and Seno Medical Instruments today announced the official signing of a licensing agreement providing VisualSonics exclusive rights to Seno Medical’s Opto-Acoustic technology for preclinical research.

Toronto, Ontario, March 16, 2007 – VisualSonics has been awarded the Best Customer Value” Award by Frost & Sullivan for its Vevo 770® micro-ultrasound system for preclinical research.

Toronto, Ontario, December 13, 2006 – In support of its growing sales efforts globally, VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced Larry McDowell has joined the company as Vice President, Sales.

Calgary, Alberta– September 29, 2006 – In recognition of his innovative concept of micro-ultrasound and its contribution to field of preclinical micro-imaging, Dr. Stuart Foster has won the 2006 Ernest C. Manning Awards Foundation’s “Award of Distinction”.

September 1, 2006 - VisualSonics Inc., the leading manufacturer of high-resolution micro-ultrasound systems, was profiled in the September 2006 issue of Genetic Engineering News (www.genengnews.com)

Toronto, Canada / Geneva, Switzerland - June 7, 2006 - VisualSonics (Toronto), the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, and Bracco Group, the foremost developer and manufacturer of ultrasound-based contrast agents, today announced an exclusive agreement for the joint development and manufacture of MicroMarker™ contrast agents.

VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced today targeted molecular imaging capabilities for its Vevo 770™ system making the platform even more powerful and quantitative for cancer researchers.

Toronto, Ontario. – February 8, 2006 – VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, today announced record growth and increased global demand for its Vevo™ platform, having recently sold its 200th system.